KAKEHASHI Inc.

KAKEHASHI Inc. is a Japan-based company specializing in digital transformation solutions for healthcare, primarily enhancing pharmacy operations and patient engagement through innovative technology platforms. Founded in 2016, KAKEHASHI Inc. operates from its headquarters in Tokyo, Japan, focusing on providing advanced digital solutions to the healthcare sector.

The company has successfully completed 8 deals, with its most recent funding round occurring on March 29, 2023, where it raised JPY 1. 8 billion in a Series C funding round, bringing the total amount raised to JPY 1. 8 billion with a current company valuation of JPY 46,559. 529 million.

The funding was backed by notable investors including Aflac Innovation Partners, Chiba Dojo, CoinBest KK, and DNX Ventures. KAKEHASHI Inc. concentrates on digital transformation (DX) solutions tailored for Japan's healthcare sector, specifically targeting approximately 60,000 pharmacies. The company's proprietary products are designed to boost operational efficiency and enhance patient experiences within these pharmacies.

Their offerings include technology platforms that facilitate streamlined pharmacy management, improved access to patient data, and better communication between healthcare providers and patients. KAKEHASHI aims to link various stakeholders in the healthcare ecosystem, addressing challenges in patient management and healthcare delivery, with potential future expansion planned for other Asian markets. KAKEHASHI Inc. generates revenue through a subscription model for its digital healthcare solutions customized for pharmacies and healthcare providers.

Clients typically engage in annual agreements that provide access to KAKEHASHI's comprehensive product suite, which includes software solutions designed for pharmacy operations and patient management. Transactions are conducted directly between KAKEHASHI and its clients, comprising pharmacies and healthcare institutions, with pricing reflecting the value added through enhanced operational efficiencies and improved patient care. Following the recent Series C funding of JPY 1. 8 billion raised on March 29, 2023, KAKEHASHI Inc.

plans to utilize the capital for recruitment, system development, service enhancement, and business expansion. The company aims to innovate further in healthcare technology, with prospective new products being designed to address evolving needs within the sector. Additionally, KAKEHASHI is exploring opportunities for geographic expansion beyond Japan, targeting other Asian markets to broaden its impact and reach.